SCHEDULE 13G
Statement of Beneficial Ownership
Definium Therapeutics, Inc. Filed Acc 0001422849-26-000171
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Capital World Investors | 8,255,584 | 6.1% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Loading xslSCHEDULE_13G_X02/primary_doc.xml…